Training Programme in Translational Medicine and Therapeutics at the University of Cambridge: 'Comprehensive analysis of structural rearrangements in the progression from Barrett's oesophagus to oesophageal adenocarcinoma.' (360G-Wellcome-095224_Z_11_Z)
Oesophageal adenocarcinoma has a dismal prognosis; median survival is < 1 year. It is thought that chromosomal rearrangements (including inversions, translocations, deletions and insertions) may play as much of a role in the development of cancer as the more thoroughly studied point mutations. Paired-end Sequencing allows rapid analysis of virtually all breakpoints in a tumour to a resolution of 500bp. Simultaneously it provides highly accurate copy number data comparable to that from arrayCGH. The Barrett's-?Dysplasia-?OAC is a well recognised paradigm. Ease of accessibility and longitudinal sampling as part of standard clinical practice provides a unique opportunity to study the biology of progression in epithelial carcinoma. Key Goals 1. Investigate structural rearrangements and copy number abnormalities involved in the genesis of oesophageal carcinoma in a small group of carefully selected patients with samples representing Barrett's oesophagus, Oesophageal adenocarcinoma and normal tissue from the same patient. 2. Confirm the importance of individual structural rearrangements by screening a large collection of primary tissue samples and comparison with clinical outcome 3. Functional assessment of potential therapeutic targets 4. Investigate the potential of personalised assays, based on unique structural rearrangements, for tumour cell-free DNA in patient serum as markers of disease status
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 97095 |
Applicant Surname | Weaver |
Approval Committee | Neurosciences And Mental Health |
Award Date | 2010-11-30T00:00:00+00:00 |
Financial Year | 2010/11 |
Grant Programme: Title | Translational Medicine & Therapeutics Programme Clinical PhD Fellow |
Internal ID | 095224/Z/11/Z |
Lead Applicant | Mr Jamie Weaver |
Partnership Value | 97095 |
Planned Dates: End Date | 2013-08-29T00:00:00+00:00 |
Planned Dates: Start Date | 2010-08-30T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | East of England |
Sponsor(s) | Prof Morris Brown |